Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pertti J Neuvonen

Showing results (21-30 of 199) with videos related to

Pageof 20
Sort By:
European Journal of Clinical Pharmacology|July 13, 2006
The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopicloneAleksi Tornio, Pertti J Neuvonen, Janne T Backman
Pharmacological Reviews|January 20, 2011
Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptakeMikko Niemi, Marja K Pasanen, Pertti J Neuvonen
Clinical Pharmacology and Therapeutics|October 4, 2006
SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatinMikko Niemi, Marja K Pasanen, Pertti J Neuvonen
Clinical Pharmacokinetics|June 20, 2008
Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatinPertti J Neuvonen, Janne T Backman, Mikko Niemi
Basic & Clinical Pharmacology & Toxicology|September 26, 2008
In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactionsMarjo J Karjalainen, Pertti J Neuvonen, Janne T Backman
Basic & Clinical Pharmacology & Toxicology|December 21, 2005
Effect of itraconazole on the pharmacokinetics of atenololJari J Lilja, Janne T Backman, Pertti J Neuvonen
European Journal of Clinical Pharmacology|January 17, 2008
Celecoxib is a CYP1A2 inhibitor in vitro but not in vivoMarjo J Karjalainen, Pertti J Neuvonen, Janne T Backman
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 10, 2014
In vitro assessment of time-dependent inhibitory effects on CYP2C8 and CYP3A activity by fourteen protein kinase inhibitorsAnne M Filppula, Pertti J Neuvonen, Janne T Backman
European Journal of Clinical Pharmacology|April 18, 2003
Prescription drugs during pregnancy and lactation--a Finnish register-based studyHeli Malm, Jaana Martikainen, Timo Klaukka, et al.
European Journal of Clinical Pharmacology|May 16, 2002
Cancer incidence among patients using antiepileptic drugs: a long-term follow-up of 28,000 patientsAnne Lamminpää, Eero Pukkala, Lyly Teppo, et al.
Pageof 20

Showing results (21-30 of 199) with videos related to

Sort By:
Pageof 20
European Journal of Clinical Pharmacology|July 13, 2006
The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopicloneAleksi Tornio, Pertti J Neuvonen, Janne T Backman
Pharmacological Reviews|January 20, 2011
Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptakeMikko Niemi, Marja K Pasanen, Pertti J Neuvonen
Clinical Pharmacology and Therapeutics|October 4, 2006
SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatinMikko Niemi, Marja K Pasanen, Pertti J Neuvonen
Clinical Pharmacokinetics|June 20, 2008
Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatinPertti J Neuvonen, Janne T Backman, Mikko Niemi
Basic & Clinical Pharmacology & Toxicology|September 26, 2008
In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactionsMarjo J Karjalainen, Pertti J Neuvonen, Janne T Backman
Basic & Clinical Pharmacology & Toxicology|December 21, 2005
Effect of itraconazole on the pharmacokinetics of atenololJari J Lilja, Janne T Backman, Pertti J Neuvonen
European Journal of Clinical Pharmacology|January 17, 2008
Celecoxib is a CYP1A2 inhibitor in vitro but not in vivoMarjo J Karjalainen, Pertti J Neuvonen, Janne T Backman
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 10, 2014
In vitro assessment of time-dependent inhibitory effects on CYP2C8 and CYP3A activity by fourteen protein kinase inhibitorsAnne M Filppula, Pertti J Neuvonen, Janne T Backman
European Journal of Clinical Pharmacology|April 18, 2003
Prescription drugs during pregnancy and lactation--a Finnish register-based studyHeli Malm, Jaana Martikainen, Timo Klaukka, et al.
European Journal of Clinical Pharmacology|May 16, 2002
Cancer incidence among patients using antiepileptic drugs: a long-term follow-up of 28,000 patientsAnne Lamminpää, Eero Pukkala, Lyly Teppo, et al.
Pageof 20